These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10610208)

  • 21. Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
    Mizutani T; Sugihara A; Honma H; Komura H; Nakamuro K; Terada N
    Gynecol Endocrinol; 2005 Feb; 20(2):80-3. PubMed ID: 15823826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas.
    Stovall TG; Ling FW; Henry LC; Woodruff MR
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1420-3; discussion 1423-5. PubMed ID: 1904681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of laparoscopic uterine artery coagulation in management of symptomatic myomas: A prospective study using ultrasound and magnetic resonance imaging.
    Simsek M; Sadik S; Taskin O; Guler H; Onoglu A; Akar M; Kursun S; Tinar S
    J Minim Invasive Gynecol; 2006; 13(4):315-9. PubMed ID: 16825073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical use of a GnRH analogue in a depot preparation (leuprolide acetate) in patients with surgical indication for uterine fibromyoma].
    Mignemi G; Garozzo A; Livatino A; Di Leo L
    Minerva Ginecol; 1994 Apr; 46(4):167-72. PubMed ID: 8065589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hysteroscopy and the treatment of uterine fibroids.
    Emanuel MH
    Best Pract Res Clin Obstet Gynaecol; 2015 Oct; 29(7):920-9. PubMed ID: 25937553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization.
    Hsieh YY; Chang CC; Tsai HD
    Taiwan J Obstet Gynecol; 2008 Mar; 47(1):66-74. PubMed ID: 18400585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [GnRH analogues in the management of uterine leiomyoma].
    Matsuo H; Maruo T
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():75-9. PubMed ID: 16689288
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful pregnancy after myomectomy using preoperative adjuvant uterine artery embolization.
    Nabeshima H; Murakami T; Sato Y; Terada Y; Yaegashi N; Okamura K
    Tohoku J Exp Med; 2003 Jul; 200(3):145-9. PubMed ID: 14521257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone metabolism in postmenopausal women who were treated with a gonadotropin-releasing hormone agonist and tibolone.
    Palomba S; Morelli M; Di Carlo C; Noia R; Pellicano M; Zullo F
    Fertil Steril; 2002 Jul; 78(1):63-8. PubMed ID: 12095492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gonadotropin releasing hormone (GnRH) agonist therapy for reduction of leiomyoma volume.
    Murphy NJ; Wallace DL
    Gynecol Oncol; 1993 May; 49(2):266-7. PubMed ID: 8504999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Massive hemoperitoneum due to rupture of an artery overlying a uterine leiomyoma: a case report.
    Horowitz E; Dekel A; Feldberg D; Rabinerson D
    Acta Obstet Gynecol Scand; 2005 Apr; 84(4):408-9. PubMed ID: 15762978
    [No Abstract]   [Full Text] [Related]  

  • 33. [Preoperative treatment with GnRH analogs in hysterectomy].
    Serrao L; Brizzi C; Primiero FM
    Clin Ter; 1994 Nov; 145(11):403-6. PubMed ID: 7889725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vesicouterine fistula and concomitant ureteric necrosis following uterine artery embolization for fibroid uterus.
    Javali T; Kasaraneni D; Banale K; Babu PS; Nagaraj HK
    Int Urogynecol J; 2015 Dec; 26(12):1877-8. PubMed ID: 26142349
    [No Abstract]   [Full Text] [Related]  

  • 35. Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial.
    Coddington CC; Grow DR; Ahmed MS; Toner JP; Cook E; Diamond MP
    Fertil Steril; 2009 May; 91(5):1909-13. PubMed ID: 18439584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical use of leuprolide acetate depot in a group of gynecologic patients in the preoperative period].
    Russo P; Ciolli P; Atlante M; Carico E; Mancini R; Russo R; Vecchione A
    Minerva Ginecol; 1998 Nov; 50(11):499-502. PubMed ID: 9882992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Laparoscopic dissection of uterine artery and coagulation utero-ovarian ligament for the treatment of symptomatic myomas].
    Szyłło K; Kulig B; Kaczmarek P; Włodarczyk B; Górski J
    Ginekol Pol; 2007 Dec; 78(12):944-51. PubMed ID: 18411917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood flow changes in the uterus induced by treatment with GnRH analogues.
    Shaw RW
    Hum Reprod; 1996 Nov; 11 Suppl 3():27-32. PubMed ID: 9147099
    [No Abstract]   [Full Text] [Related]  

  • 39. [Surgical treatment of subserosal fibroids: the cons].
    Marret H; Ouldamer L
    Gynecol Obstet Fertil; 2011; 39(7-8):454-7. PubMed ID: 21752689
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis.
    Friedman AJ; Lobel SM; Rein MS; Barbieri RL
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1114-9. PubMed ID: 2145765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.